Lexicon Pharmaceuticals (LXRX) Announces 22% Reduction in Workforce
More News related to LXRX
- Lexicon Pharma (LXRX) Posts Q3 Loss of $0.14
- Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Third Quarter Financial Results
- Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
- Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2009 Financial Results on October 27, 2009
- Lexicon Announces Completion of Public Offering of Common Stock
More News related to Corporate News
- After-Hours Movers 11/09: SGK, PCLN, SQNM Higher; MBI, SDTH, UTK, TOPS, CPST, BTN, FLR Lower
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
- Unusual 11 Mid-Day Movers 11/09: EONC, EWBC, REV, PRST Higher; GTN, CHNG, SRZ, CHDX Lower
- Notable Analyst Rating Changes: RSH, ANF, NOC, ADBE, HERO Upgraded; RIMM, RHT, GPS, AZN, SGY Downgraded
- Morning Movers 11/09: EWBC, CVM, REV, CGEN, RSH Higher; CHDX, SRZ, GTN, RPRX, VSR Lower
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announceda restructuring of its operations to conserve capital and direct resources towards its most advanced drug discovery and development programs. The restructuring will involve a workforce reduction of 102 employees, primarily in basic research, early-stage discovery and support positions, representing approximately 22% of its total workforce.
Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease.[SM]
Related Categories
Corporate NewsStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
